Lv41
580 积分 2021-08-16 加入
MUC17 is a potential new prognostic biomarker and promotes pancreatic cancer progression in obstructive jaundice
1小时前
已完结
Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management
2天前
已关闭
Optimizing current treatment of gout
2天前
已完结
Uric acid and chronic kidney disease: which is chasing which?
2天前
已完结
Acquired resistance mechanisms to osimertinib: The constant battle
9天前
已完结
Gout
24天前
已完结
Controversies and practical management of patients with gout and chronic kidney disease
27天前
已完结
Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions
27天前
已完结
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
1个月前
已完结
Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications
1个月前
已关闭
皖公网安备34019202002308
